Is Exparel Approved for Popliteal Blocks? A Guide to FDA Status and Use
•
5 min read
As of November 2023, the U.S. Food and Drug Administration (FDA) has approved an expanded label for Exparel, specifically indicating its use for a sciatic nerve block in the popliteal fossa in adults. This makes it a standard, FDA-approved option for regional anesthesia in specific foot and ankle surgeries.